Share This Link

Ultrasound in the first trimester can reliably detect multiple gestations. It can visualize the presence of multiple gestational sacs or fetal poles, clearly indicating whether a woman is carrying twins, triplets, or more.
Early identification of multiple gestations is crucial for optimal pregnancy management. It allows healthcare providers to tailor prenatal care, monitor for potential complications associated with multiple pregnancies, and plan for appropriate delivery. Choice C rationale:
Ultrasound in the first trimester can assist in detecting certain maternal abnormalities that could impact pregnancy. These may include:
Uterine abnormalities, such as fibroids or structural defects
Ovarian cysts
Ectopic pregnancies (where the embryo implants outside the uterus)
Gestational trophoblastic disease (abnormal growth of tissue inside the uterus)
Early identification of these maternal abnormalities allows for timely intervention and management, ensuring the best possible outcomes for both mother and fetus.

Ultrasound in the first trimester can assist in detecting certain maternal abnormalities that could impact pregnancy. These may include:

Uterine abnormalities, such as fibroids or structural defects

Ovarian cysts

Ectopic pregnancies (where the embryo implants outside the uterus)

Gestational trophoblastic disease (abnormal growth of tissue inside the uterus)

Early identification of these maternal abnormalities allows for timely intervention and management, ensuring the best possible outcomes for both mother and fetus.

Confirming pregnancy is a primary reason for ultrasound in the first trimester. It can visualize the gestational sac, which contains the developing embryo and confirms the presence of a pregnancy.
Ultrasound can also detect the fetal heartbeat, which typically becomes visible between 6 and 8 weeks gestation. This provides further confirmation of a viable pregnancy.

A positive contraction stress test (CST) indicates a potential problem with the fetal heart's response to uterine contractions, not spontaneous accelerations.
It's not consistent with the findings in this scenario.

A negative CST would show no late decelerations in response to contractions, but it's not relevant here because contractions weren't induced.

A non-reactive NST lacks the required accelerations, which are present in this case.

Satisfactory is not a standard interpretation for a contraction stress test (CST).
While a normal FHR with no decelerations is generally reassuring, the specific terminology used for a negative CST is "negative."
Using "satisfactory" could lead to potential ambiguity or misunderstanding among healthcare professionals.

Unsatisfactory is used when the CST results are inconclusive or concerning for fetal well-being.
This typically occurs when there are late decelerations in the FHR, suggesting uteroplacental insufficiency and potential fetal hypoxia.
However, in this scenario, there are no decelerations, so "unsatisfactory" is not an appropriate interpretation.

Positive is used when there are late decelerations in the FHR during the CST.
Late decelerations are a sign of uteroplacental insufficiency, which can potentially lead to fetal hypoxia and acidosis.
A positive CST often warrants further evaluation and assessment of fetal well-being, and may even necessitate interventions such as early delivery.
However, in the absence of late decelerations, a positive CST result is not applicable.

Share your situation with friends and family so they can provide support.
While sharing with friends and family can be helpful for some couples, it's important to recognize that not everyone may be able to provide the kind of support that is needed. Some friends and family members may not understand the challenges of infertility or may offer unsolicited advice, which can be hurtful. Additionally, couples may not feel comfortable sharing such personal information with their loved ones. It's important to respect the couple's privacy and preferences in this regard.

Start adoption proceedings immediately as it can be challenging to adopt an infant.
This response is not appropriate as it does not address the couple's immediate concern, which is how to maintain their emotional balance while dealing with infertility. It also assumes that the couple is interested in adoption, which may not be the case. While adoption can be a wonderful option for some families, it's a major decision that requires careful consideration and should not be rushed into.

Speak only with other friends who are dealing with infertility as they can provide the most help.
While connecting with others who are experiencing infertility can be helpful, it's important not to isolate oneself from other sources of support. Friends and family who are not dealing with infertility can still offer valuable support, understanding, and companionship. It's important to have a variety of supportive relationships in one's life.

Drug/alcohol use: While substance abuse during pregnancy can lead to adverse outcomes such as preterm labor, fetal growth restriction, and birth defects, it is not considered a primary factor in determining high-risk status for this patient. The specific substances involved (cocaine and alcohol) are indeed associated with risks, but they are not as significant as other factors in this case.
Age: The patient's age of 24 is not considered a high-risk factor for pregnancy. Advanced maternal age (typically defined as 35 years or older) is associated with increased risks for chromosomal abnormalities and other complications, but this patient falls below that age threshold.
Family history: Family history of diabetes mellitus, cancer, and neural tube defects can be relevant to pregnancy risk, but in this case, other factors outweigh their significance.

Blood pressure: The patient's blood pressure of 108/70 mm Hg is within the normal range and does not contribute to highrisk categorization. High blood pressure (hypertension) during pregnancy can lead to preeclampsia and other complications, but this patient does not present with hypertension.
Age: As explained in Choice A, the patient's age is not a high-risk factor.
BMI: A BMI of 17 is considered underweight, which can increase the risk of certain pregnancy complications such as preterm birth and low birth weight. However, in this case, other factors are more significant in determining high-risk status.

Age: As explained previously, the patient's age is not a high-risk factor.
BMI: The patient's BMI is a contributing factor, but not the most significant one in this case.
Family history: The patient's family history is relevant, but the presence of a neural tube defect in a close relative is the most significant aspect of her family history in terms of pregnancy risk.

Urine output (UO) does not completely stop during the oliguric phase of acute renal failure. While it is significantly reduced, some urine production still occurs. Complete cessation of urine output is known as anuria, which is a more severe condition and a medical emergency.
Anuria may occur in the most severe cases of acute renal failure, but it is not the defining characteristic of the oliguric phase.
It's crucial to distinguish between oliguria and anuria, as their management approaches differ significantly.

Urine output (UO) is always measured during the oliguric phase of acute renal failure. It is a vital clinical indicator to monitor the severity of kidney dysfunction and guide treatment decisions.
Accurate measurement of urine output is essential for assessing fluid balance, kidney function, and the effectiveness of treatment interventions.

Urine output (UO) is not greater than 500 mL/24 hours during the oliguric phase of acute renal failure. A urine output greater than 500 mL/24 hours would indicate a non-oliguric phase of acute renal failure or a potential recovery phase.

Walking can indeed help to speed up labor by using gravity to help the baby descend.
However, once Misoprostol has been administered, the woman is usually asked to lie on her side for about 30 to 40 minutes to allow the medication to be absorbed.
After that, if the healthcare provider agrees, she may be able to walk around.

Monitoring the baby’s heart rate and the woman’s contraction pattern is a standard procedure during labor and delivery.
This allows the healthcare team to ensure the safety of both the mother and the baby.
It is especially important when medications like Misoprostol are used, as they can cause changes in the frequency and strength of contractions.

Nausea and vomiting are potential side effects of Misoprostol.
However, not all women experience these side effects, and if they do occur, they are usually temporary.
The healthcare provider can offer solutions to manage these side effects if they become bothersome.

Incorrect. The quad screen test does not examine fetal DNA to determine gender. That is the role of other tests, such as amniocentesis or chorionic villus sampling (CVS).
Gender determination is not a primary objective of the quad screen test.
Focusing on gender unnecessarily narrows the scope of the test's potential findings.

Incorrect. The quad screen test does not use fetal tissue. It is a non-invasive blood test that measures levels of four substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A.
Fetal tissue sampling is more invasive and carries risks, while the quad screen is a safer alternative.
Clarifying the non-invasive nature of the test is crucial for informed consent and patient understanding.

Incorrect. While AFP levels can be affected by maternal liver function, that is not the primary focus of the quad screen test.
Liver function tests are specifically designed to assess liver health, and they are not part of the quad screen panel.
Distinguishing between liver function assessment and AFP's role in screening for fetal anomalies is essential for accurate interpretation.

Neural tube defects (NTDs) are birth defects that affect the brain, spine, or spinal cord.
The most common NTDs are spina bifida and anencephaly.
The NT test is not a diagnostic test for NTDs, although it might detect some cases of open spina bifida.
However, it's not specifically designed for this purpose, and other tests, such as alpha-fetoprotein (AFP) screening or detailed ultrasound, are more reliable for diagnosing NTDs.

The NT test is typically performed in the first trimester of pregnancy, between 11 and 14 weeks gestation.
It's not available in the second trimester because the nuchal translucency measurement becomes less reliable after this point in pregnancy.

A nuchal translucency measurement of 3mm or less is generally considered normal.
Measurements greater than 3mm are associated with an increased risk of Down syndrome and other chromosomal abnormalities.
The higher the measurement, the greater the risk.